Last week, ASPHALION participated in the Final Consortium General Assembly (CGA) of the Horizon Project VASCOVID, which aimed at developing a Portable Platform for the Assessment of microvascular health in Covid-19 patients at the intensive care. The meeting was held at Parc Taulí Hospital Universitari and it served to summarize all the accomplishments and tasks performed during the project in its 2 years of life, as well as for the preparation of future plans both for the device and for the partners.
ASPHALION, MedTech Regulatory Expert Partner, was represented by Diego Sanoja, who contributed to the meeting and presented updates on the preparation of the Technical Documentation for CE Marking, Risk Assessment Report and the Regulatory and Clinical Pathway for the future of the project.
Should you require further information, you can contact us at: info@asphalion.com
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101016087
